Presentations and Speakers
1) Conducting a Failure Analysis:
Failure analysis is a detailed process utilizing analytical methodology and techniques as well as good detective work. The objective of a failure investigation should be to determine a root cause that may eventually lead to corrective action to minimize future occurrences. While understanding the fracture behavior of metals may often lead to a determination of the fracture mode and mechanics, other factors such as design, manufacturing process and service conditions are critical to ascertain the circumstances that led to the failure. Often the complexity of a failure will require knowledge outside of materials science will require additional methodology such as modeling, and advanced analytical techniques. A general outline will be presented of the failure analysis process with specific examples.
John O. Ratka is the Manager, Failure Analysis at Stork Herron Testing Laboratories located in Cleveland, OH. Stork Herron is a full service metallurgical and analytical laboratory where John leads a team conducting failure analysis and metallurgical consulting. Prior to joining Stork Herron, John was Director of The Advanced Materials Commercialization Center, an Ohio Third Frontier Program, in Lima, Ohio where he oversaw the design and construction of a unique large-scale PVD coating demonstration facility. During a 25 year metallurgical career at Brush Wellman Inc. he was R&D Supervisor and Laboratory Manager. John earned a Bachelors degree in Biomedical Engineering and a Masters degree in Material Science from Case Western Reserve University in Cleveland, OH.
2) Use of the Scanning Electron Microscope for Failure Analysis:
The Scanning Electron Microscope (SEM) is a very valuable tool in failure analysis. The SEM provides the capability for viewing at not only low but also very high magnifications, routinely up to 10,000 - 15,000 times. It has a depth of field which is much greater than any optical microscope or metallograph. An additional capability is that the SEM can give micro-chemical analysis of area being viewed by incorporating either Energy Dispersive Spectrometry (EDS) or Wavelength Dispersive Spectrometry (WDS). The talk will describe the benefits of the SEM/EDS system in failure analysis and will be illustrated by numerous failure evaluations.
Jeffrey L. Blough, P.E. is a supervisor of the Metallurgy Group in FirstEnergy's BETA Lab. He is currently responsible for metallurgical services supporting the FirstEnergy nuclear, fossil, hydro, transmission and distribution companies and plants. Jeff also performs metallurgical evaluations for outside customers including the utility refinery, petrochemical and pulp/paper industries. He is the author or co-author of 45 papers and a
licensed professional engineer in the State of California. Jeff is a member of the National Association of Corrosion Engineers and ASMI. He holds a B.S. in Physics from Alma College - 1969 and a M.S. in Metallurgical Engineering from the Ohio State University ? 1972
Christopher R. Holp is a Senior Nuclear Specialist for FirstEnergy's BETA Labs. He is currently the principal operator of the Scanning Electron Microscopes (SEM) and Image Analysis (IA) systems with FirstEnergy Nuclear Operating Company. He is responsible for conducting fractographic evaluations and materials characterizations through the use of SEM/EDS and IA. His 20+ years of experience includes exposure to many ferrous, nonferrous, and engineered materials. Chris is a member of the Microbeam Analysis Society.
3) Legal Aspects of Failure Analysis:
This talk discusses the legal and liability issues associated with failures. What could some responsible person have done, in the exercise of reasonable prudence, to prevent the injury from happening? What does strict liability really mean, in view of:
- Defective design
- Defective manufacture
- Failure to warn
- Reasonably foreseeable uses, modifications, or alterations of the product
- Reasonably foreseeable misuses
- The technical and economic feasibility of using an alternative design
Insight into risk/ benefit analysis, failsafe design, and the role of the expert in product liability cases is also given.
Stephen John Brown, Esq. is a practicing attorney and owner of Stephen J. Brown Co. LPA in Median Ohio. He is a certified Civil Trial Specialist, NBTA; a former Governing Trustee of the Ohio chapter of the American Board of Trial Advocates; a Life Fellow of the ABOTA Foundation; a Life Fellow of the Ohio State Bar Foundation; a Fellow of the Roscoe Pound Foundation. He commonly lectures for the Ohio Association for Justice, Regional Seminar Committee as a seminar lecturer in criminal law, insurance law, and negligence law. He has been a faculty member of the ATLA National College of Advocacy, 1985, 1988, 1991, 1995, 1997; a lecturer in negligence law for the Ohio State Bar Association; a faculty member of civil trial advocacy seminars for Cleveland State Law School. Steve received his B.B.A. at Case Western Reserve University, 1966 and his J.D. at Cleveland State University, 1970. He is admitted to the Bar in Ohio, various U.S. District Courts, and the U. S. Supreme Court. Steve is a member of the Ohio Association for Justice (former trustee), the Ohio State Bar Association (Negligence Law Committee, former member Council of Delegates), and the American Association for Justice, the American Board of Trial Advocates, and the Medina County Bar Association (president 1983).
4) Breakage of Uncemented Modular Revision Stems: What Have We Learned for the Future?
Modularity in total hip arthroplasty design, both primary and revision, has received increased citation in the clinical literature. The advantages of these systems include off-the-shelf flexibility for custom proximal and distal canal filling, restoration of offset and construct stability as well as accommodating difficult situations of femoral deformity, limb length inequality and bone loss. Clinical concerns in their application include the maintenance of anatomical stability within the femoral canal, structural compromise at metal-metal interconnections due to cyclic microdisplacements (fretting) contributing to early stem breakage, and increased potential for metallic wear debris generation.
In order to predict the anticipated in vivo service life of contemporary modular femoral designs, pre-clinical structural fatigue curves should be obtained. One of the essential characteristics of this curve is the endurance limit, which is defined as the maximum dynamic load an implant system can support and theoretically never fail. Once a baseline curve is developed for a given device, material, design and loading alterations can be studied to determine their affect on implant longevity. These parametric variations are part of a contemporary design process and help to ensure in vivo longevity.
Another important feature of laboratory fatigue testing is the location of crack initiation and its consistency for a given design. Location variability is suggestive of structural weak points which may be attributed to manufacture, design and component finishing.
Developing a structural fatigue curve for modular femoral hip stems is a straightforward, mechanical solution to evaluate the influence of design, manufacture and material choices on anticipated in vivo longevity. It should be an imperative of every implant manufacturer to perform this pre-clinical testing to avoid device failure in an orthopaedic patient.
Dr. A. Seth Greenwald is the President of Orthopaedic Research Laboratories. He is an internationally recognized bio-academician, thought leader and educator with more than 30 years of experience as a productive researcher in areas of joint biomechanics and artificial implants. He is the originator of the prestigious Current Concepts in Joint Replacement meetings. Dr. Greenwald received his doctorate in orthopaedic and engineering sciences from Oxford University, England in 1970 and holds advanced degrees from the Massachusetts Institute of Technology and Columbia University.
Dr. Greenwald is an active member of many professional associations, including the American Academy of Orthopaedic Surgeons, the American Orthopaedic Association, the Orthopaedic Research Society, the Girdlestone Society and both the Hip and Knee Societies. Throughout the span of his career, Dr. Greenwald has held numerous prominent appointments within leading organizations, in both the public and private sectors, including the Food and Drug Administration.
Dr. Greenwald has also received numerous prestigious honors and awards, most notably the Kappa Delta for recognition of outstanding orthopaedic basic science research, and is a National Science Foundation Science Faculty Fellow.
